Assisting Nature
9
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
11%
1 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection
Role: lead
Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection
Role: lead
Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.
Role: lead
A New Revolutionary 3-Injection- Protocol in Infertile Women
Role: lead
Hysteroscopy With Fundus Uterus Scratching Incision VS Office Hysteroscopy Before ET With Donor Eggs
Role: lead
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol
Role: lead
Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol
Role: lead
The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate
Role: lead
Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix
Role: lead
All 9 trials loaded